Substance / Medication

Streptokinase

Overview

Active Ingredient
streptokinase
RxNorm CUI
10106

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

2 trials linked to this intervention

2
Total Trials
0
Recruiting
0
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Intraventricular streptokinase after intraventricular hemorrhage in newborn infants.
Whitelaw A, Odd D E · Cochrane Database Syst Rev · 2007
PMID: 17943743Meta-AnalysisFull text (PMC)
Intraventricular streptokinase after intraventricular hemorrhage in newborn infants.
Whitelaw A · Cochrane Database Syst Rev · 2001
PMID: 11279695Meta-Analysis
Intraventricular streptokinase after intraventricular hemorrhage in newborn infants.
Whitelaw A · Cochrane Database Syst Rev · 2000
PMID: 10796211Meta-Analysis
Six Versus Three Doses of Intrapleural Streptokinase in Childhood Empyema: A Randomized Controlled Trial.
Thakur Chirag, Mathew Joseph L, Saxena Akshay K et al. · Pediatr Pulmonol · 2025
PMID: 39739340RCT
Safety and Efficacy of Pharmaco-invasive Approach Using Streptokinase Compared With Primary Percutaneous Coronary Angiography.
Sultan El-Zahraa M, Elberry Ahmed A, Rabea Hoda et al. · Crit Pathw Cardiol · 2021
PMID: 33337729RCT
Streptokinase Versus Unfractionated Heparin Nebulization in Patients With Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial With Observational Controls.
Abdelaal Ahmed Mahmoud Ahmed, Mahmoud Hatem Elmoutaz, Mahran Mohamed Ali et al. · J Cardiothorac Vasc Anesth · 2020
PMID: 31262641RCT
Timing of adverse events during fibrinolytic therapy with streptokinase for left-sided prosthetic valve thrombosis.
Karthikeyan Ganesan, Mathew Navin, Math Ravi S et al. · J Thromb Thrombolysis · 2011
PMID: 21416132RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Streptokinase (substance)
SNOMED CT
395889004
UMLS CUI
C0038418
RxNorm CUI
10106

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

4
Conditions
3
Biomarkers
2
Specialists
0
Symptoms
2
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.

Streptokinase — Conditions, Biomarkers & Specialists | Healos | Healos